Breast Cancer Drug Is So Effective, Study Is Halted
From Times Wire Reports
Women with advanced breast cancer soon may have another treatment option: A novel experimental drug delayed the growth of tumors nearly twice as long as standard chemotherapy did in patients who had stopped responding to Herceptin, doctors in Atlanta reported.
The experimental drug, Tykerb, worked so well that an international study of it was stopped early and all participants were offered the drug.
Charles Geyer Jr. of Allegheny General Hospital in Pittsburgh reported results at a meeting of the American Society of Clinical Oncology.
